Cargando…
增强剂量免疫化疗联合一线自体外周血造血干细胞移植治疗年轻、高危侵袭性B细胞淋巴瘤疗效及预后因素分析
OBJECTIVE: This study aimed to determine the efficacy of dose-enhanced immunochemotherapy followed by autologous peripheral blood stem cell transplantation(ASCT)in young patients with newly diagnosed high-risk aggressive B-cell lymphoma. METHODS: A retrospective study was conducted to examine the cl...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072063/ https://www.ncbi.nlm.nih.gov/pubmed/35405779 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.03.006 |
Ejemplares similares
-
自体和异基因造血干细胞移植治疗60例高危外周T细胞淋巴瘤患者的疗效比较
Publicado: (2016) -
外周血造血干细胞移植治疗侵袭性外周T细胞淋巴瘤41例临床分析
Publicado: (2018) -
非小细胞肺癌脑转移高危因素研究进展
Publicado: (2022) -
我如何治疗新诊断的年轻高危弥漫大B细胞淋巴瘤
Publicado: (2016) -
自体造血干细胞移植治疗25例侵袭性外周T细胞淋巴瘤患者临床分析
Publicado: (2015)